Page last updated: 2024-09-03

pramipexole and Peripheral Nerve Injuries

pramipexole has been researched along with Peripheral Nerve Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Escalona, PR; Haynes, MK; Milligan, ED; Noor, S; Pasmay, A; Sanchez, JE; Sanchez, JJ; Sklar, LA; Sun, MS; Vanderwall, AG; Zimmerly, J	1

Other Studies

1 other study(ies) available for pramipexole and Peripheral Nerve Injuries

Article	Year
The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture. Neuroscience letters, 2023, 09-25, Volume: 814 Topics: Animals; Cell Culture Techniques; Cytokines; Drugs, Investigational; Humans; Hyperalgesia; Interleukin-10; Mice; Neuralgia; Peripheral Nerve Injuries; Pramipexole; Rats; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord	2023

Article

Year

The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture.

Neuroscience letters, 2023, 09-25, Volume: 814

Topics: Animals; Cell Culture Techniques; Cytokines; Drugs, Investigational; Humans; Hyperalgesia; Interleukin-10; Mice; Neuralgia; Peripheral Nerve Injuries; Pramipexole; Rats; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord

2023